Copeland Capital Management, LLC Novo Nordisk A S Transaction History
Copeland Capital Management, LLC
- $5.61 Billion
- Q3 2024
A detailed history of Copeland Capital Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Copeland Capital Management, LLC holds 107 shares of NVO stock, worth $8,620. This represents 0.0% of its overall portfolio holdings.
Number of Shares
107Holding current value
$8,620% of portfolio
0.0%Shares
34 transactions
Others Institutions Holding NVO
# of Institutions
1,911Shares Held
318MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.63 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.16 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.15 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.07 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$984 Million3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $182B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...